S'abonner

Prevalence of Secondary Hypertension in Otherwise Healthy Youths with a New Diagnosis of Hypertension: A Meta-Analysis - 06/05/22

Doi : 10.1016/j.jpeds.2022.01.047 
James T. Nugent, MD, MPH 1, 2, , Chelsea Young, MD 1, Melissa C. Funaro, MS, MLS 3, Kuan Jiang, BS 2, Ishan Saran, BS 2, Lama Ghazi, MD, PhD 2, F. Perry Wilson, MD, MSCE 2, 4, Jason H. Greenberg, MD, MHS 1, 2
1 Section of Nephrology, Department of Pediatrics, Yale University School of Medicine, New Haven, CT 
2 Clinical and Translational Research Accelerator, Department of Medicine, Yale University School of Medicine, New Haven, CT 
3 Harvey Cushing/John Hay Whitney Medical Library, Yale University School of Medicine, New Haven, CT 
4 Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, CT 

Reprint requests: James T. Nugent, MD, MPH, Clinical and Translational Research Accelerator, Department of Medicine, Yale University School of Medicine, 60 Temple St, Ste 6C, New Haven, CT 06510.Clinical and Translational Research AcceleratorDepartment of MedicineYale University School of Medicine60 Temple St, Ste 6CNew HavenCT06510

Abstract

Objective

To estimate the prevalence of secondary hypertension among otherwise healthy children with hypertension diagnosed in the outpatient setting.

Study design

The MEDLINE, PubMed Central, Embase, Web of Science, and Cochrane Library databases were systematically searched for observational studies reporting the prevalence of secondary hypertension in children who underwent evaluation for hypertension and had no known comorbidities associated with hypertension at the time of diagnosis. Two authors independently extracted the study-specific prevalence of secondary hypertension in children evaluated for hypertension. Prevalence estimates for secondary hypertension were pooled in a random-effects meta-analysis.

Results

Nineteen prospective studies and 7 retrospective studies including 2575 children with hypertension were analyzed, with a median of 65 participants (range, 9-486) in each study. Studies conducted in primary care or school settings reported a lower prevalence of secondary hypertension (3.7%; 95% CI, 1.2%-7.2%) compared with studies conducted in referral clinics (20.1%; 95% CI, 11.5%-30.3%). When stratified by study setting, there were no significant subgroup differences according to study design, country, participant age range, hypertension definition, blood pressure device, or study quality. Although the studies applied different approaches to diagnosing secondary hypertension, diagnostic evaluations were at least as involved as the limited testing recommended by current guidelines.

Conclusions

The low prevalence of secondary hypertension among children with a new diagnosis of hypertension identified on screening reinforces clinical practice guidelines to avoid extensive testing in the primary care setting for secondary causes in most children with hypertension.

Le texte complet de cet article est disponible en PDF.

Keywords : secondary hypertension, primary hypertension, high blood pressure, systematic review, meta-analysis

Abbreviations : AAP, ABPM


Plan


 F.W. has received funding through Grants R01 DK113191 and P30 DK079310 from the National Institute of Diabetes and Digestive and Kidney Diseases and Grant R01 HS027626 from the Agency for Healthcare Research and Quality, United States. J.G. has received funding through Grant K08 DK110536 from the National Institute of Diabetes and Digestive and Kidney Diseases and the Child Health Foundation, United States. The authors declare no conflicts of interest.
 Portions of this study were presented as an abstract during the American Society of Nephrology Kidney Week, San Diego, CA, November 4-7, 2021.


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 244

P. 30 - mai 2022 Retour au numéro
Article précédent Article précédent
  • International Variation in the Management of Patent Ductus Arteriosus and Its Association with Infant Outcomes: A Survey and Linked Cohort Study
  • Tetsuya Isayama, Satoshi Kusuda, Mark Adams, Elettra Berti, Malcolm Battin, Kjell Helenius, Stellan Håkansson, Maximo Vento, Mikael Norman, Brian Reichman, Akihiko Noguchi, Shoo K. Lee, Dirk Bassler, Kei Lui, Liisa Lehtonen, Junmin Yang, Prakesh S. Shah, International Network for Evaluating Outcomes of Neonates (iNeo) Investigators
| Article suivant Article suivant
  • Genome Analysis in Sick Neonates and Infants: High-yield Phenotypes and Contribution of Small Copy Number Variations
  • Hisato Suzuki, Masatoshi Nozaki, Hiroshi Yoshihashi, Kazuo Imagawa, Daigo Kajikawa, Mamiko Yamada, Yu Yamaguchi, Naoya Morisada, Mayuko Eguchi, Shoko Ohashi, Shinsuke Ninomiya, Toshiyuki Seto, Tomoharu Tokutomi, Mariko Hida, Katsuaki Toyoshima, Masatoshi Kondo, Ayano Inui, Kenji Kurosawa, Rika Kosaki, Yushi Ito, Nobuhiko Okamoto, Kenjiro Kosaki, Toshiki Takenouchi

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.